Development and Validation of a Nomogram for Predicting the Long-Term Survival in Patients With Chronic Thromboembolic Pulmonary Hypertension

被引:3
|
作者
Hu, Song [1 ]
Tan, Jiang-Shan [1 ]
Liu, Sheng [2 ]
Guo, Ting-Ting [1 ]
Song, Wu [2 ]
Peng, Fu-Hua [1 ]
Wu, Yan [1 ]
Gao, Xin [1 ]
Hua, Lu [1 ]
机构
[1] Chinese Acad Med Sci & Peking Union Med Coll, Fuwai Hosp, Thrombosis Ctr,Natl Ctr Cardiovasc Dis,State Key, Natl Clin Res Ctr Cardiovasc Dis,Key Lab Pulm Vas, Beijing, Peoples R China
[2] Chinese Acad Med Sci & Peking Union Med Coll, Fuwai Hosp, Adult Cardiac Surg Ctr, Natl Ctr Cardiovasc Dis,Dept Cardiac Surg, Beijing, Peoples R China
关键词
ARTERIAL-HYPERTENSION; RISK STRATIFICATION; MANAGEMENT; HYPOXIA;
D O I
10.1016/j.amjcard.2021.09.045
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
There remains a lack of prognosis models for patients with chronic thromboembolic pulmonary hypertension (CTEPH). This study aims to develop a nomogram predicting 3-, 5-, and 7-year survival in patients with CTEPH and verify the prognostic model. Patients with CTEPH diagnosed in Fuwai Hospital were enrolled consecutively between May 2013 and May 2019. Among them, 70% were randomly split into a training set and the other 30% as a validation set for external validation. Cox proportional hazards model was used to identify the potential survival-related factors which were candidate variables for the establishment of nomogram and the final model was internally validated by the bootstrap method. A total of 350 patients were included in the final analysis and the median followup period of the whole cohort was 51.2 months. Multivariate analysis of Cox proportional hazards regression showed body mass index, mean right atrial pressure, N-terminal probrain natriuretic peptide (per 500 ng/ml increase in concentration), presence of anemia, and main treatment choice were the independent risk factors of mortality. The nomogram demonstrated good discrimination with the corrected C-index of 0.82 in the training set, and the C-index of 0.80 (95% CI: 0.70 to 0.91) in the external validation set. The calibration plots also showed a good agreement between predicted and actual survival in both training and validation sets. In conclusion, we developed an easy-to-use nomogram with good apparent performance using 5 readily available variables, which may help physicians to identify CTEPH patients at high risk for poor prognosis and implement medical interventions. (C) 2021 Elsevier Inc. All rights reserved.
引用
收藏
页码:109 / 116
页数:8
相关论文
共 50 条
  • [1] The long-term survival in patients with chronic thromboembolic pulmonary hypertension: experience from a single center in China
    Hu, Song
    Tan, Jiang-Shan
    Liu, Sheng
    Guo, Ting-Ting
    Song, Wu
    Peng, Fu-Hua
    Wu, Yan
    Gao, Xin
    Hua, Lu
    JOURNAL OF THROMBOSIS AND THROMBOLYSIS, 2022, 53 (04) : 926 - 933
  • [2] Long-Term Outcome of Patients With Chronic Thromboembolic Pulmonary Hypertension Results From an International Prospective Registry
    Delcroix, Marion
    Lang, Irene
    Pepke-Zaba, Joanna
    Jansa, Pavel
    D'Armini, Andrea M.
    Snijder, Repke
    Bresser, Paul
    Torbicki, Adam
    Mellemkjaer, Soren
    Lewczuk, Jerzy
    Simkova, Iveta
    Barbera, Joan A.
    de Perrot, Marc
    Hoeper, Marius M.
    Gaine, Sean
    Speich, Rudolf
    Gomez-Sanchez, Miguel A.
    Kovacs, Gabor
    Jais, Xavier
    Ambroz, David
    Treacy, Carmen
    Morsolini, Marco
    Jenkins, David
    Lindner, Jaroslav
    Dartevelle, Philippe
    Mayer, Eckhard
    Simonneau, Gerald
    CIRCULATION, 2016, 133 (09) : 859 - 871
  • [3] Notch ratio in pulmonary flow predicts long-term survival after pulmonary endarterectomy for chronic thromboembolic pulmonary hypertension
    Beijk, M. A. M.
    Winkelman, J. A.
    Eckmann, H. M.
    Samson, D. A.
    Widyanti, A. P.
    Vleugels, J.
    Bombeld, D. C. M.
    Meijer, C. G. C. M.
    Bogaard, H. J.
    Noordegraaf, A. Vonk
    de Bruin-Bon, H. A. C. M.
    Bouma, B. J.
    HEART AND VESSELS, 2024, 39 (11) : 968 - 978
  • [4] Long-term efficacy of bosentan in inoperable chronic thromboembolic pulmonary hypertension
    Post, M. C.
    Plokker, H. W. M.
    Kelder, J. C.
    Snijder, R. J.
    NETHERLANDS HEART JOURNAL, 2009, 17 (09): : 329 - 333
  • [5] Echocardiography Nomogram for Predicting Survival among Chronic Lung Disease Patients with Severe Pulmonary Hypertension
    Jiang, Rong
    Wang, Lan
    Zhao, Qin-Hua
    Wu, Cheng
    Yuan, Ping
    Wang, Shang
    Zhang, Rui
    Gong, Su-Gang
    Wu, Wen-Hui
    He, Jing
    Qiu, Hong-Ling
    Luo, Ci-Jun
    Liu, Jin-Ming
    Jing, Zhi-Cheng
    JOURNAL OF CLINICAL MEDICINE, 2022, 11 (06)
  • [6] Long-term clinical value and outcome of riociguat in chronic thromboembolic pulmonary hypertension
    van Thor, M. C. J.
    ten Klooster, L.
    Snijder, R. J.
    Post, M. C.
    Mager, J. J.
    IJC HEART & VASCULATURE, 2019, 22 : 163 - 168
  • [7] Long-Term Outcome of Chronic Thromboembolic Pulmonary Hypertension at a Single Japanese Pulmonary Endarterectomy Center
    Miwa, Hideki
    Tanabe, Nobuhiro
    Jujo, Takayuki
    Kato, Fumiaki
    Anazawa, Rie
    Yamamoto, Keiko
    Naito, Akira
    Kasai, Hajime
    Nishimura, Rintaro
    Suda, Rika
    Sugiura, Toshihiko
    Sakao, Seiichiro
    Ishida, Keiichi
    Masuda, Masahisa
    Tatsumi, Koichiro
    CIRCULATION JOURNAL, 2018, 82 (05) : 1428 - +
  • [8] Association of anemia and long-term survival in patients with pulmonary hypertension
    Krasuski, Richard A.
    Hart, Stephen A.
    Smith, Brad
    Wang, Andrew
    Harrison, J. Kevin
    Bashore, Thomas M.
    INTERNATIONAL JOURNAL OF CARDIOLOGY, 2011, 150 (03) : 291 - 295
  • [9] Long-term health-related quality of life after surgery in patients with chronic thromboembolic pulmonary hypertension
    Kamenskaya, Oksana
    Klinkova, Asya
    Chernyavskiy, Aleksander
    Lomivorotov, Vladimir V.
    Edemskiy, Alexander
    Shmyrev, Vladimir
    QUALITY OF LIFE RESEARCH, 2020, 29 (08) : 2111 - 2118
  • [10] Predictors of long-term survival in pulmonary hypertension
    Wilkens, Heinrike
    Held, Matthias
    LANCET RESPIRATORY MEDICINE, 2016, 4 (05) : 338 - 339